ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.65
-0.26%
US Tech 100
19,168.00
0.52%
S&P 500
5,431.60
-0.04%
US Dollar vs CAD
1.37515
0.00%
Bitcoin
66,218.43
0.04%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Astrazeneca Plc (AZN)

  7. Astrazeneca Plc (AZN) News

AZN

Astrazeneca (AZN)

Astrazeneca Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:AZN
DateTimeSourceHeadlineSymbolCompany
06/12/20242:56PMAlliance NewsAlliance NewsAstraZeneca's Farxiga approved to treat paediatric type-2 diabetesLSE:AZNAstrazeneca Plc
06/12/20242:56PMAlliance NewsAlliance NewsAstraZeneca's Farxiga approved to treat paediatric type-2 diabetesLSE:AZNAstrazeneca Plc
06/12/20249:00AMRNS Regulatory NewsAstraZeneca PLC Director/PDMR ShareholdingLSE:AZNAstrazeneca Plc
06/10/20242:30AMAlliance NewsAlliance NewsTOP NEWS: Astra's Tagrisso gets US priority review for lung cancerLSE:AZNAstrazeneca Plc
06/10/20242:30AMAlliance NewsAlliance NewsTOP NEWS: Astra's Tagrisso gets US priority review for lung cancerLSE:AZNAstrazeneca Plc
06/05/20243:27AMAlliance NewsAlliance NewsAstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchaseLSE:AZNAstrazeneca Plc
06/05/20243:27AMAlliance NewsAlliance NewsAstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchaseLSE:AZNAstrazeneca Plc
06/05/20241:00AMRNS Regulatory NewsAstraZeneca PLC Acquisition of Fusion completedLSE:AZNAstrazeneca Plc
06/04/20246:00AMPR Newswire (US)AbelZeta announces clinical data showing preliminary anti-tumor activity for C-CAR031, an armored autologous GPC3 CAR-T, in patients with advanced hepatocellular carcinoma, at ASCO Annual Meeting 2024LSE:AZNAstrazeneca Plc
06/03/20249:05AMRNS Regulatory NewsAstraZeneca PLC Block listing Interim ReviewLSE:AZNAstrazeneca Plc
06/03/20249:00AMRNS Regulatory NewsAstraZeneca PLC Total Voting RightsLSE:AZNAstrazeneca Plc
06/03/20242:59AMAlliance NewsAlliance NewsAstraZeneca cancer treatment Tagrisso recommended for approval in EULSE:AZNAstrazeneca Plc
06/03/20242:59AMAlliance NewsAlliance NewsAstraZeneca cancer treatment Tagrisso recommended for approval in EULSE:AZNAstrazeneca Plc
06/03/20241:00AMRNS Regulatory NewsAstraZeneca PLC Tagrisso plus chemo recommended for approval in EULSE:AZNAstrazeneca Plc
05/29/20242:54AMAlliance NewsAlliance NewsIN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trialLSE:AZNAstrazeneca Plc
05/29/20242:54AMAlliance NewsAlliance NewsIN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trialLSE:AZNAstrazeneca Plc
05/28/20241:00AMRNS Regulatory NewsAstraZeneca PLC Dato-DXd improved OS in nonsquamous lung cancerLSE:AZNAstrazeneca Plc
05/27/20241:49AMAlliance NewsAlliance NewsIN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXdLSE:AZNAstrazeneca Plc
05/27/20241:49AMAlliance NewsAlliance NewsIN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXdLSE:AZNAstrazeneca Plc
05/21/20246:18AMAlliance NewsAlliance NewsEXTRA: AstraZeneca pins hopes on pipeline as plans new era of growthLSE:AZNAstrazeneca Plc
05/21/20246:18AMAlliance NewsAlliance NewsEXTRA: AstraZeneca pins hopes on pipeline as plans new era of growthLSE:AZNAstrazeneca Plc
05/21/20242:18AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aimLSE:AZNAstrazeneca Plc
05/21/20242:18AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aimLSE:AZNAstrazeneca Plc
05/21/20241:00AMRNS Regulatory NewsAstraZeneca PLC AstraZeneca to deliver $80bn revenue by 2030LSE:AZNAstrazeneca Plc
05/20/20242:24AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca plans to build manufacturing plant in SingaporeLSE:AZNAstrazeneca Plc
05/20/20242:24AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca plans to build manufacturing plant in SingaporeLSE:AZNAstrazeneca Plc
05/20/20241:00AMRNS Regulatory NewsAstraZeneca PLC AstraZeneca to manufacture ADCs in SingaporeLSE:AZNAstrazeneca Plc
05/16/20244:27AMAlliance NewsAlliance NewsAstraZeneca trials yield positive results for immunocompromised patientsLSE:AZNAstrazeneca Plc
05/16/20244:27AMAlliance NewsAlliance NewsAstraZeneca trials yield positive results for immunocompromised patientsLSE:AZNAstrazeneca Plc
05/16/20241:00AMRNS Regulatory NewsAstraZeneca PLC SUPERNOVA Trial Met COVID-19 prevention endpointLSE:AZNAstrazeneca Plc
 Showing the most relevant articles for your search:LSE:AZN

Your Recent History

USOTC
ERHE
ERHC Energy (CE)
USOTC
AABB
Asia Broadband (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
CNNA
Cann American (CE)
USOTC
HHSE
Hannover House (PK)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
CIVX
CTR Investments and Cons... (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
COIN
SHIBUSD
SHIBA INU
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
BLLB
Bell Buckle (PK)
USOTC
RNVA
Rennova Health (PK)
NASDAQ
LWLG
Lightwave Logic
NASDAQ
DJT
Trump Media and Technology
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved